
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multidrug-Resistant Microbial Therapy Using Antimicrobial Peptides and the CRISPR/Cas9 System
Yared Abate Getahun, Destaw Asfaw Ali, Bihonegn Wodajnew Taye, et al.
Veterinary Medicine Research and Reports (2022) Vol. Volume 13, pp. 173-190
Open Access | Times Cited: 32
Yared Abate Getahun, Destaw Asfaw Ali, Bihonegn Wodajnew Taye, et al.
Veterinary Medicine Research and Reports (2022) Vol. Volume 13, pp. 173-190
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 67
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 67
Molecular Aspects of the Functioning of Pathogenic Bacteria Biofilm Based on Quorum Sensing (QS) Signal-Response System and Innovative Non-Antibiotic Strategies for Their Elimination
Edyta Juszczuk‐Kubiak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2655-2655
Open Access | Times Cited: 25
Edyta Juszczuk‐Kubiak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2655-2655
Open Access | Times Cited: 25
New Frontiers in CRISPR: Addressing Antimicrobial Resistance with Cas9, Cas12, Cas13, and Cas14
Ahmed S.A. Ali Agha, Ali Al‐Samydai, Talal Aburjaı
Heliyon (2025) Vol. 11, Iss. 2, pp. e42013-e42013
Open Access | Times Cited: 2
Ahmed S.A. Ali Agha, Ali Al‐Samydai, Talal Aburjaı
Heliyon (2025) Vol. 11, Iss. 2, pp. e42013-e42013
Open Access | Times Cited: 2
Advantages and Challenges of Using Antimicrobial Peptides in Synergism with Antibiotics for Treating Multidrug-Resistant Bacteria
Regina Meneses Gonçalves, Bruna Estéfani Dutra Monges, Karen G. N. Oshiro, et al.
ACS Infectious Diseases (2025)
Open Access | Times Cited: 2
Regina Meneses Gonçalves, Bruna Estéfani Dutra Monges, Karen G. N. Oshiro, et al.
ACS Infectious Diseases (2025)
Open Access | Times Cited: 2
Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts
Ahmad Almatroudi
Biology (2025) Vol. 14, Iss. 2, pp. 165-165
Open Access | Times Cited: 1
Ahmad Almatroudi
Biology (2025) Vol. 14, Iss. 2, pp. 165-165
Open Access | Times Cited: 1
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 21
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 21
Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance
Hiva Kadkhoda, Pourya Gholizadeh, Hossein Samadi Kafil, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34692-e34692
Open Access | Times Cited: 7
Hiva Kadkhoda, Pourya Gholizadeh, Hossein Samadi Kafil, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34692-e34692
Open Access | Times Cited: 7
CRISPR-Cas System: A Tool to Eliminate Drug-Resistant Gram-Negative Bacteria
Rajeshwari Rajesh Kundar, Karuna Gokarn
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1498-1498
Open Access | Times Cited: 25
Rajeshwari Rajesh Kundar, Karuna Gokarn
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1498-1498
Open Access | Times Cited: 25
CRISPR/Cas9 gene editing: a novel strategy for fighting drug resistance in respiratory disorders
Bashdar Mahmud Hussen, Zana B. Najmadden, Snur Rasool Abdullah, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Bashdar Mahmud Hussen, Zana B. Najmadden, Snur Rasool Abdullah, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Developing a Versatile Arsenal: Novel Antimicrobials as Offensive Tools Against Pathogenic Bacteria
Junze Ma, Zheng Lu
Microorganisms (2025) Vol. 13, Iss. 1, pp. 172-172
Open Access
Junze Ma, Zheng Lu
Microorganisms (2025) Vol. 13, Iss. 1, pp. 172-172
Open Access
CRISPR-Based Gene Editing in Acinetobacter baumannii to Combat Antimicrobial Resistance
Muhammad Junaid, Krit Thirapanmethee, Piyatip Khuntayaporn, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 920-920
Open Access | Times Cited: 9
Muhammad Junaid, Krit Thirapanmethee, Piyatip Khuntayaporn, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 920-920
Open Access | Times Cited: 9
Beyond antibiotics: CRISPR/Cas9 triumph over biofilm-associated antibiotic resistance infections
Azna Zuberi, Nayeem Ahmad, Hafiz Ahmad, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Azna Zuberi, Nayeem Ahmad, Hafiz Ahmad, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Analysis of Gut Microbial Communities and Resistance Genes in Pigs and Chickens in Central China
Yapei Rui, Gang Qiu
Animals (2022) Vol. 12, Iss. 23, pp. 3404-3404
Open Access | Times Cited: 10
Yapei Rui, Gang Qiu
Animals (2022) Vol. 12, Iss. 23, pp. 3404-3404
Open Access | Times Cited: 10
The Antimicrobial Peptide LJ-hep2 from Lateolabrax japonicus Exerting Activities against Multiple Pathogenic Bacteria and Immune Protection In Vivo
Ruihao Gong, Zhe An, Weibin Zhang, et al.
Marine Drugs (2022) Vol. 20, Iss. 10, pp. 651-651
Open Access | Times Cited: 9
Ruihao Gong, Zhe An, Weibin Zhang, et al.
Marine Drugs (2022) Vol. 20, Iss. 10, pp. 651-651
Open Access | Times Cited: 9
Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems
Guillermo Aquino‐Jarquín
Drug Discovery Today (2023) Vol. 28, Iss. 11, pp. 103793-103793
Closed Access | Times Cited: 5
Guillermo Aquino‐Jarquín
Drug Discovery Today (2023) Vol. 28, Iss. 11, pp. 103793-103793
Closed Access | Times Cited: 5
Insight on the mechanism of hexameric Pseudin-4 against bacterial membrane-mimetic environment
A. S. Vinutha, R. Rajasekaran
Journal of Computer-Aided Molecular Design (2023) Vol. 37, Iss. 9, pp. 419-434
Closed Access | Times Cited: 4
A. S. Vinutha, R. Rajasekaran
Journal of Computer-Aided Molecular Design (2023) Vol. 37, Iss. 9, pp. 419-434
Closed Access | Times Cited: 4
Therapeutic proteins have the potential to become new weapons in the fight against antibiotic resistance
Mohamed Reda Halawa, Maxwell Akantibila, Briana E. Reid, et al.
Frontiers in Bacteriology (2023) Vol. 2
Open Access | Times Cited: 4
Mohamed Reda Halawa, Maxwell Akantibila, Briana E. Reid, et al.
Frontiers in Bacteriology (2023) Vol. 2
Open Access | Times Cited: 4
Phytophenolic derivatives as potential ameliorative agents for microbial superbugs: mechanisms of action, cellular pathways and synergistic selectivity with chemotherapeutics
Michael Tosin Bayode, Elizabeth Foluke Awodire, Emmanuel Ojo, et al.
Deleted Journal (2024) Vol. 6, Iss. 9
Open Access | Times Cited: 1
Michael Tosin Bayode, Elizabeth Foluke Awodire, Emmanuel Ojo, et al.
Deleted Journal (2024) Vol. 6, Iss. 9
Open Access | Times Cited: 1
CRISPR-Cas9 system: a potent tool to fight antibiotic resistance in bacteria
Arka Moitra, Abhinaba Chakraborty, Bomba Dam
The Microbe (2024), pp. 100184-100184
Open Access | Times Cited: 1
Arka Moitra, Abhinaba Chakraborty, Bomba Dam
The Microbe (2024), pp. 100184-100184
Open Access | Times Cited: 1
Role of CRISPR-Cas System as a New Approach in Fighting the Antimicrobial Resistance of Bacterial and Viral Pathogens
Heba Mohammed Refat M. Selim, Fatma Alzahraa M. Gomaa, Mohammad Y. Alshahrani, et al.
Infectious Diseases & Immunity (2024)
Open Access | Times Cited: 1
Heba Mohammed Refat M. Selim, Fatma Alzahraa M. Gomaa, Mohammad Y. Alshahrani, et al.
Infectious Diseases & Immunity (2024)
Open Access | Times Cited: 1
Investigating the genetic basis of disease resistance in animal populations
Shaymaa Naser Ridha
World Journal of Advanced Research and Reviews (2023) Vol. 18, Iss. 1, pp. 073-079
Open Access | Times Cited: 3
Shaymaa Naser Ridha
World Journal of Advanced Research and Reviews (2023) Vol. 18, Iss. 1, pp. 073-079
Open Access | Times Cited: 3
Revolutionizing Antimicrobial Solutions Nanotechnology, CRISPR-Cas9 and Innovative Approaches to Combat Drug Resistance in ESKAPE Pathogens
J. Sabarish Sachithanandan, M Deepalakshmi, H. Rajamohamed, et al.
Journal of Pure and Applied Microbiology (2024) Vol. 18, Iss. 2, pp. 808-822
Open Access
J. Sabarish Sachithanandan, M Deepalakshmi, H. Rajamohamed, et al.
Journal of Pure and Applied Microbiology (2024) Vol. 18, Iss. 2, pp. 808-822
Open Access
A Comprehensive Review on the Antibacterial, Antifungal, Antiviral, and Antiparasitic Potential of Silybin
José Lima Pereira Filho, Amanda Graziela Gonçalves Mendes, Carmem Duarte Lima Campos, et al.
Antibiotics (2024) Vol. 13, Iss. 11, pp. 1091-1091
Open Access
José Lima Pereira Filho, Amanda Graziela Gonçalves Mendes, Carmem Duarte Lima Campos, et al.
Antibiotics (2024) Vol. 13, Iss. 11, pp. 1091-1091
Open Access
How new generation techniques are shaping the future of environmental sciences
Agnieszka Gruszecka‐Kosowska, Antonios Ampatzoglou, Javier Pineda‐Pampliega, et al.
Frontiers in Environmental Chemistry (2023) Vol. 4
Open Access | Times Cited: 1
Agnieszka Gruszecka‐Kosowska, Antonios Ampatzoglou, Javier Pineda‐Pampliega, et al.
Frontiers in Environmental Chemistry (2023) Vol. 4
Open Access | Times Cited: 1
Sağlık Bilimleri Araştırmaları: Temel Tıp-III
Can Cengiz, Meral Ekim, Hasan Ekim, et al.
Özgür Yayınları eBooks (2023)
Open Access
Can Cengiz, Meral Ekim, Hasan Ekim, et al.
Özgür Yayınları eBooks (2023)
Open Access